[Imaging in Large-Vessel Vasculitis. What Works Best in Giant Cell Arteritis and Takayasu Arteritis?]

Insights

Giant cell arteritis and Takayasu arteritis are large-vessel vasculitides requiring prompt diagnosis. Advanced imaging techniques like ultrasound and MRI are crucial for detecting inflammation and guiding treatment to prevent complications.

Area of Science:

  • Rheumatology
  • Cardiology
  • Radiology

Background:

  • Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are primary systemic vasculitides affecting large vessels.
  • GCA is the most common vasculitis, while TAK predominantly affects young women.
  • Early diagnosis and treatment are crucial to prevent irreversible complications such as visual loss, stenosis, occlusion, and aneurysms.

Purpose of the Study:

  • To review current and emerging imaging modalities for diagnosing and monitoring GCA and TAK.
  • To highlight the strengths and limitations of various imaging techniques in assessing vascular inflammation and disease activity.

Main Methods:

  • Vascular ultrasound for high-resolution assessment of cranial and extracranial vessels in GCA.
  • Magnetic resonance imaging (MRI) as a gold standard for TAK, assessing mural inflammation and luminal pathology.
  • 18F]FDG PET/CT for whole-body assessment in GCA and complementary role in TAK, despite limitations in specificity and persistent uptake.
  • Emerging tracers ([18F]FAPI, [68Ga]Ga-DOTA-Siglec-9) and novel ocular imaging for GCA.

Main Results:

  • Vascular ultrasound detects signs like the halo sign and increased intima-media thickness in GCA.
  • MRI provides detailed, radiation-free assessment of inflammation and pathology in TAK.
  • [18F]FDG PET/CT aids in identifying extracranial involvement in GCA but has limited specificity.
  • Disease activity monitoring in both GCA and TAK remains challenging due to persistent vascular changes that may not reflect active inflammation.

Conclusions:

  • Imaging plays a transformative role in the diagnosis and management of GCA and TAK.
  • A multimodal imaging approach, combining ultrasound, MRI, and PET/CT, is often necessary for comprehensive evaluation.
  • Ongoing research into novel imaging tracers and techniques promises to improve the accuracy and sensitivity of disease detection and monitoring.